Latin America Multiomics Market (2026-2031)
The Latin America Multiomics Market was valued at $86 Million in 2026 and projected to reach to $142.8 Million by 2031, representing a compound annual growth rate of 10.7%. Latin America's multiomics market is positioned for sustained growth as healthcare systems modernize and research capabilities expand across the region.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Latin America Multiomics Market Trends and Insights
- This growth trajectory reflects Latin America's increasing adoption of advanced genomic and proteomic technologies across research institutions, diagnostic centers, and pharmaceutical companies.
- Latin America is positioning itself as a key emerging market within the global multiomics landscape, driven by rising healthcare investments and growing demand for precision medicine solutions. The multiomics sector in Latin America is benefiting from improved access to sequencing platforms, bioinformatics infrastructure, and collaborative research initiatives.
- Latin America's healthcare systems are increasingly recognizing the value of integrated omics data for disease diagnosis, drug development, and personalized treatment strategies.
- Between 2026 and 2031, Latin America is expected to see accelerated adoption among academic medical centers and contract research organizations, supported by regional government funding and international partnerships that strengthen the region's scientific capabilities..
Key Market Statistics
- CAGR (2026-2031) 10.7% CAGR
- Market Size, 2026 ~USD 86 Million
- Forecast, 2031 ~USD 142.8 Million
- Geography Latin America
Latin America Multiomics Market Overview
Market Valuation Growth :
Latin America's multiomics market is valued at $86.0 million in 2026 and is projected to reach $142.8 million by 2031, demonstrating robust expansion driven by increasing healthcare investments and research infrastructure development across the region.
Regional CAGR Performance :
The Latin American multiomics market is growing at a compound annual growth rate of 10.7% from 2026 to 2031, reflecting steady adoption of advanced genomic and proteomic technologies in research institutions and diagnostic centers throughout the region.
Brazil's Market Leadership :
Brazil represents the largest multiomics market in Latin America with $53.0 million in market size, serving as the primary hub for pharmaceutical research, clinical diagnostics, and genomic innovation initiatives across the region.
Technology Adoption Acceleration :
Latin American research institutions and pharmaceutical companies are increasingly integrating multiomics platforms for precision medicine, biomarker discovery, and drug development, supported by growing government funding and international collaborations.
Latin America Multiomics Market Dynamics
- Investment in genomic infrastructure, coupled with rising demand for personalized medicine and precision diagnostics, is driving adoption among pharmaceutical companies, academic institutions, and clinical laboratories.
- Brazil's leadership in the market is complemented by emerging opportunities in Mexico, Argentina, and Colombia, where healthcare modernization initiatives are accelerating multiomics technology implementation. The region's growth trajectory is supported by increasing government funding for life sciences research, partnerships with international biotech firms, and growing awareness of multiomics applications in disease diagnosis and treatment.
- As Latin American countries strengthen their regulatory frameworks for genomic testing and expand access to advanced diagnostic technologies, the multiomics market is expected to capture greater market share within the broader healthcare innovation landscape through 2031..
Market Ecosystem
MULTIOMICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Provides Illumina Connected Multiomics, a cloud-based platform that integrates and analyzes genomics, transcriptomics, proteomics, epigenomics, and other multiomic datasets. For example, oncology researchers at the University of Colorado Anschutz Medical Campus used the platform to analyze proteomic data and generate insights into melanoma biology. | Enables integrated analysis of multiple biological data layers, helping researchers identify biomarkers, understand disease mechanisms, and accelerate precision medicine and drug discovery. (Illumina) |
 |
Provides Chromium Single Cell Multiome ATAC + Gene Expression technology, enabling simultaneous profiling of chromatin accessibility and gene expression in individual cells. Its platforms are widely used in cancer, immunology, and developmental biology research to characterize cellular states and regulatory mechanisms. | Provides a comprehensive view of gene regulation at single-cell resolution, helping researchers link regulatory elements with gene expression and identify disease-associated cell populations. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Latin America's multiomics market will grow from $86.0M (2026) to $142.8M (2031) at a 10.7% CAGR.
- Latin America is emerging as a key regional hub for precision medicine and genomic research adoption.
- Latin America's growth is driven by increased healthcare infrastructure investment and international research collaborations.
- Latin America's multiomics sector is expanding fastest in academic medical centers and contract research organizations.
Multiomics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SERVICES (Offering) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 12.3% from 2026 to 2031 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 3.19 (2026) |
| Revenue Forecast (Billions) | ~USD 5.7 (2031) |
| Segments Covered | Offering, Type, Technology, Method, Workflow, Application, End User |
Latin America Multiomics Market Report Segmentation
7 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Assay Kits & Reagents
- Consumables
- Instruments & Software
- Long-Read Sequencing
- Ms-Based Proteomics
- Nanopore Sequencing
- Ngs-Based Proteomics
- Other Consumables
- Other Proteomics Methods
- Other Sequencing Technologies
- Pcr-Based Proteomics
- Smrt Sequencing
By Technology
- Long-Read Sequencing
- Nanopore Sequencing
- Other Sequencing Technologies
- Other Technologies
- Proteomics
- Sequencing
- Smrt Sequencing
By Method
- Chromatin Accessibility Sequencing
- Chromatin Interaction Analysis
- Dna Methylation Sequencing
- Epigenomics
- Histone Modification Profiling
- Long-Range Sequencing
- Long-Read & Long-Range Sequencing
- Long-Read Sequencing
- Ms-Based Proteomics
- Ngs-Based Proteomics
- Other Epigenomics Methods
- Other Long-Read & Long-Range Sequencing Methods
- Other Methods
- Other Proteomics Methods
- Other Single-Cell Omics
- Other Spatial Omics
- Pcr-Based Proteomics
- Proteomics
- Sequencing-Based Epigenomics
- Single-Cell Epigenomics
- Single-Cell Genomics
- Single-Cell Omics
- Single-Cell Proteomics
- Single-Cell Transcriptomics
- Spatial Epigenomics
- Spatial Genomics
- Spatial Omics
- Spatial Proteomics
- Spatial Transcriptomics
By Workflow
- Data Visualization & Analysis
- Sample Preparation
- Sequencing & Analysis/ Sample Characterization
- Sequencing & Analysis/Sample Characterization
By Application
- Biomarker Discovery
- Cell Biology
- Clinical Diagnostics
- Drug Discovery & Development
- Immunology
- Neurology
- Oncology
- Other Applications
- Precision Medicine
- Translational Research
By End User
- Academic & Research Institutes
- Cros & Cdmos
- Hospitals & Diagnostic/Clinical Laboratories
- Pharmaceutical & Biotechnology Companies
Target Audience
- Pharmaceutical & Biotech Companies : Require detailed market intelligence on Latin America's multiomics adoption to guide R&D investments, clinical trial strategies, and precision medicine product launches in the region.
- Diagnostic & Laboratory Service Providers : Need market sizing and growth forecasts to assess expansion opportunities, technology investments, and service offerings in Latin American diagnostic centers and clinical laboratories.
- Healthcare Technology Vendors : Seek regional market data to identify demand for genomic and proteomic platforms, understand competitive positioning, and develop localized solutions for Latin American healthcare institutions.
- Research & Academic Institutions : Utilize market insights to secure funding, justify infrastructure investments in multiomics capabilities, and benchmark research initiatives against regional and global standards.
- Healthcare Investors & Consultants : Require comprehensive market analysis to evaluate investment opportunities, assess portfolio company positioning, and provide strategic guidance for multiomics-focused ventures in Latin America.
Countries within Latin America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| Brazil | USD 53 Million |
| Rest Of Latin America | USD 60 Million |
Country market size visualization
Reasons to Buy this Report
- Regional Market Sizing & Forecasts : Obtain precise market valuations for Latin America's multiomics sector with detailed projections through 2031, enabling accurate budget allocation and strategic planning for market entry or expansion initiatives.
- Country-Level Breakdown Analysis : Access granular market data for Brazil and Rest of Latin America segments, identifying high-growth opportunities and competitive landscapes within specific geographic markets for targeted business development.
- Technology Adoption Trends : Understand the adoption patterns of genomic and proteomic technologies across Latin American research institutions, diagnostic centers, and pharmaceutical companies to inform product development and go-to-market strategies.
- Competitive Intelligence : Benchmark your organization against regional market dynamics and identify key players, partnerships, and investment trends shaping the multiomics landscape in Latin America.
- Growth Driver Identification : Discover the primary factors fueling 10.7% CAGR growth in Latin America, including healthcare modernization, government funding, and precision medicine demand, to capitalize on emerging opportunities.
Frequently asked questions
What is the current size of the multiomics market in Latin America?
Latin America's multiomics market was valued at $86.0 million in 2026 and is expected to reach $142.8 million by 2031.
What is the projected growth rate for multiomics in Latin America?
Latin America's multiomics market is projected to grow at a compound annual growth rate (CAGR) of 10.7% from 2026 to 2031.
Which sectors are driving multiomics adoption in Latin America?
Latin America's multiomics adoption is primarily driven by academic medical centers, diagnostic laboratories, pharmaceutical companies, and contract research organizations seeking precision medicine solutions.
What factors are supporting multiomics market growth in Latin America?
Latin America's multiomics growth is supported by increased healthcare investments, improved bioinformatics infrastructure, international research partnerships, and rising demand for personalized medicine approaches.
How does Latin America's multiomics market compare to global trends?
Latin America's multiomics market is growing at 10.7% CAGR, slightly below the global average of 12.3%, reflecting the region's emerging market status and ongoing infrastructure development.
RESEARCH METHODOLOGY
This study involved four major activities in estimating the current size of the multiomics market. Exhaustive secondary research was conducted to gather information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Following this, the data triangulation procedure was used to estimate the market size of segments and subsegments.
Secondary Research
Secondary research was primarily used to identify and gather information for the extensive, technical, market-oriented, and commercial study. The secondary sources referred for this research study include publications from government sources, such as the National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), European Bioinformatics Institute (EMBL-EBI), US Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), and Organisation for Economic Co-operation and Development (OECD). Omics-specific repositories and research initiatives, including Human Protein Atlas, the Cancer Genome Atlas (TCGA), Genotype-Tissue Expression (GTEx), Clinical Proteomic Tumor Analysis Consortium (CPTAC), among several others. Secondary sources also included corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. These sources were also used to obtain key information on major players, global product revenues, market classification, and segmentation by industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data were collected and analyzed to determine the overall size of the global Multiomics market, and the findings were validated through primary research.
Primary Research
In-depth interviews were conducted with primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess market prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the multiomics market was estimated through multiple approaches. A detailed market estimation approach was used to estimate and validate the market value and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Multiomics Market : Top-Down and Bottom-Up Approach
Data Triangulation
After estimating the overall market size from the market size estimation process, the total market was split into several segments. To complete the overall market engineering process and arrive at the exact statistics for all segments, the data triangulation procedure was employed; it involved studying various factors and trends from both the demand and supply sides.
Market Definition
The multiomics market comprises commercial revenues generated from products and services used to perform integrated multiomics analyses by combining two or more molecular profiling modalities, such as genomics, epigenomics, transcriptomics, proteomics, and spatial or single-cell omics. The market includes instruments, software, assay kits, reagents, consumables, and analytical services supporting advanced multiomics workflows from sample preparation and molecular characterization to data integration, visualization, and interpretation. These technologies are used across research and clinical applications, including oncology, precision medicine, biomarker discovery, translational research, drug discovery, and clinical diagnostics, by pharmaceutical and biotechnology companies, academic and research institutions, hospitals, diagnostic laboratories, CROs, and CDMOs. The market excludes conventional single-omics technologies, routine short-read sequencing workflows, microarray-based molecular profiling, and general laboratory products not specifically designed for integrated multiomics applications.
Key Stakeholders
- Multiomics product & service providers
- Multiomics bioinformatics/data analysis companies
- Venture capitalists and other government funding organizations
- Research and consulting firms
- Hospitals and diagnostic clinics
- Pharmaceutical and biotechnology companies
- Academic and government research institutes
- Life science companies
Report Objectives
- To define, describe, and forecast the multiomics market by offering, method, technology, workflow, application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall multiomics market
- To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America (US and Canada), Europe (Germany, France, the UK, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America), the Middle East [GCC Countries (Saudi Arabia (KSA), United Arab Emirates (UAE), and the Rest of GCC Countries) and the Rest of Middle East], and Africa
- To profile the key players and analyze their market shares and core competencies
- To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
- To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographical Analysis
- Further breakdown of the Rest of Europe multiomics market, by country
- Further breakdown of the Rest of Asia Pacific multiomics market, by country
Company Analysis
- Detailed analysis and profiling of additional market players (up to five)
Segment Analysis
- Cross-segment analysis
Get the Full Multiomics Market Report
Full forecast, segment splits, and company analysis for all Multiomics Market.
- Canada Multiomics Market
- US Multiomics Market
- Germany Multiomics Market
- UK Multiomics Market
- France Multiomics Market
- Italy Multiomics Market
- Spain Multiomics Market
- China Multiomics Market
- Japan Multiomics Market
- South Korea Multiomics Market
- India Multiomics Market
- Australia Multiomics Market
- Brazil Multiomics Market
- Saudi Arabia Multiomics Market
- UAE Multiomics Market
- Rest Of Europe Multiomics Market
- Rest Of Asia Pacific Multiomics Market
- Rest Of Latin America Multiomics Market
- Rest Of GCC Countries Multiomics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
